COVID-19
The universal coronavirus vaccine targets the low-mutation stalk region of the virus.
Christian Olsen, VP of Dotmatics, describes how COVID-19 forever altered drug development timelines.
COVID-19 infection may increase the risk of heart attack, stroke and all-cause mortality up to three years post-infection.
Jason Okulicz, of Gilead Sciences, discusses a study that showed remdesivir reduces mortality in elderly patients with COVID.
Heart failure patients who are vaccinated against COVID-19 have a considerably greater likelihood of living longer.
Dr. Bob Walker discusses high blood pressure in the context of severe COVID-19 infection.
Advertisement
Expert Interviews on COVID-19
Advertisement
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.